{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:25:36Z","timestamp":1790943936744,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.nbd.2008.01.015","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T15:16:31Z","timestamp":1205334991000},"page":"312-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Wenzhen","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Tryggestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Ladenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Lud","family":"Cadet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1386","key":"10.1016\/j.nbd.2008.01.015_bb0005","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1098\/rstb.1999.0451","article-title":"Are there multiple pathways in the pathogenesis of Huntington's disease?","volume":"354","author":"Aronin","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond., B Biol. Sci."},{"issue":"9369","key":"10.1016\/j.nbd.2008.01.015_bb0010","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","article-title":"Huntingtin aggregation and toxicity in Huntington's disease","volume":"361","author":"Bates","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.nbd.2008.01.015_bb0015","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1471-4159.1990.tb03143.x","article-title":"Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid","volume":"55","author":"Beal","year":"1990","journal-title":"J. Neurochem."},{"issue":"18","key":"10.1016\/j.nbd.2008.01.015_bb0020","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1089\/10430349950016393","article-title":"Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer","volume":"10","author":"Bemelmans","year":"1999","journal-title":"Hum. Gene Ther."},{"issue":"14","key":"10.1016\/j.nbd.2008.01.015_bb0025","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.4161\/cc.5.14.2929","article-title":"New directions for neurodegenerative disease therapy: using chemical compounds to boost the formation of mutant protein inclusions","volume":"5","author":"Bodner","year":"2006","journal-title":"Cell Cycle"},{"issue":"35","key":"10.1016\/j.nbd.2008.01.015_bb0030","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.nbd.2008.01.015_bb0035","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jnr.20344","article-title":"Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF","volume":"78","author":"Cepeda","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2008.01.015_bb0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","article-title":"Transcriptional dysregulation in Huntington's disease","volume":"23","author":"Cha","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2008.01.015_bb0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1750-3639.2006.00009.x","article-title":"Neural stem cell systems: diversities and properties after transplantation in animal models of diseases","volume":"16","author":"Conti","year":"2006","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2008.01.015_bb0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0166-2236(02)02143-4","article-title":"Exercise: a behavioral intervention to enhance brain health and plasticity","volume":"25","author":"Cotman","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2008.01.015_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0070-2153(06)75002-5","article-title":"Selective neuronal degeneration in Huntington's disease","volume":"75","author":"Cowan","year":"2006","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.nbd.2008.01.015_bb0060","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1073\/pnas.1532244100","article-title":"Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain","volume":"100","author":"Curtis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.01.015_bb0065","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1440-1681.2007.04609.x","article-title":"Progenitor cells and adult neurogenesis in neurodegenerative diseases and injuries of the basal ganglia","volume":"34","author":"Curtis","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.nbd.2008.01.015_bb0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuroimage.2005.01.039","article-title":"Magnetic resonance imaging at microscopic resolution reveals subtle morphological changes in a mouse model of dopaminergic hyperfunction","volume":"26","author":"Cyr","year":"2005","journal-title":"NeuroImage"},{"issue":"10","key":"10.1016\/j.nbd.2008.01.015_bb0075","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1088\/0031-9155\/52\/10\/007","article-title":"The small-animal radiation research platform (SARRP): dosimetry of a focused lens system","volume":"52","author":"Deng","year":"2007","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.nbd.2008.01.015_bb0080","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intracellular inclusions and dystrophic neuritis in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2008.01.015_bb0085","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","article-title":"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice","volume":"100","author":"Duan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.01.015_bb0090","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.20075","article-title":"Paroxetine retards disease onset and progression in Huntingtin mutant mice","volume":"55","author":"Duan","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.01.015_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1385\/NMM:5:1:011","article-title":"Role of neurotrophic factors in the etiology and treatment of mood disorders","volume":"5","author":"Duman","year":"2004","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.nbd.2008.01.015_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0896-6273(00)81132-0","article-title":"Polyglutamine expansions: proteolysis, chaperones, and the dangers of promiscuity","volume":"26","author":"Ferrigno","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2008.01.015_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.01.015_bb0110","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.nbd.2005.05.006","article-title":"Reduced hippocampal neurogenesis in R6\/2 transgenic Huntington's disease mice","volume":"20","author":"Gil","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2008.01.015_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0006-8993(02)02505-2","article-title":"Modulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro","volume":"941","author":"Goggi","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2008.01.015_bb0120","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","article-title":"Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine","volume":"22","author":"Grote","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2008.01.015_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S0033291799002871","article-title":"The molecular biology of Huntington's disease","volume":"31","author":"Ho","year":"2001","journal-title":"Psychol. Med."},{"key":"10.1016\/j.nbd.2008.01.015_bb0130","doi-asserted-by":"crossref","first-page":"18189","DOI":"10.1073\/pnas.0506375102","article-title":"FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease","volume":"102","author":"Jin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.nbd.2008.01.015_bb0135","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ymthe.2004.02.016","article-title":"AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease","volume":"9","author":"Kells","year":"2004","journal-title":"Molec. Ther."},{"issue":"3","key":"10.1016\/j.nbd.2008.01.015_bb0140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410220318","article-title":"Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum","volume":"22","author":"Kish","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.01.015_bb0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0306-4522(99)00400-5","article-title":"Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopamine-lesioned rats","volume":"95","author":"Krasnova","year":"2000","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.nbd.2008.01.015_bb0150","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","article-title":"Huntington aggregates may not predict neuronal death in Huntington's disease","volume":"46","author":"Kuemmerle","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.01.015_bb0155","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.nbd.2008.01.015_bb0160","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00001756-200404090-00014","article-title":"Decreased hippocampal cell proliferation in R6\/1 Huntington's mice","volume":"15","author":"Lazic","year":"2004","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2008.01.015_bb0165","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1046\/j.1471-4159.2002.01085.x","article-title":"Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice","volume":"82","author":"Lee","year":"2002","journal-title":"J. Neurochem."},{"issue":"16","key":"10.1016\/j.nbd.2008.01.015_bb0170","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","article-title":"Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease","volume":"27","author":"Lynch","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.01.015_bb0175","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.tips.2005.10.005","article-title":"Antidepressant action: to the nucleus and beyond","volume":"26","author":"Malberg","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2008.01.015_bb0180","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1046\/j.1471-4159.1995.65041740.x","article-title":"Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons","volume":"65","author":"Mattson","year":"1995","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.nbd.2008.01.015_bb0185","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.arr.2004.08.001","article-title":"A neural signaling triumvirate that influences ageing and age-related disease: insulin\/IGF-1, BDNF and serotonin","volume":"3","author":"Mattson","year":"2004","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.nbd.2008.01.015_bb0190","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.0508875103","article-title":"Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease","volume":"103","author":"McBride","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.01.015_bb0195","first-page":"4021","article-title":"Extreme sensitivity of adult neurogenesis to low doses of X-irradiation","volume":"63","author":"Mizumatsu","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.nbd.2008.01.015_bb0200","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2174\/156802606778249810","article-title":"Serotonin reuptake inhibitors: the corner stone in treatment of depression for half a century\u2014a medicinal chemistry survey","volume":"6","author":"Moltzen","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"issue":"9","key":"10.1016\/j.nbd.2008.01.015_bb0205","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nm749","article-title":"Irradiation induces neural precursor-cell dysfunction","volume":"8","author":"Monje","year":"2002","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.nbd.2008.01.015_bb0210","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.38.3.341","article-title":"Clinical and neuropathologic assessment of severity in Huntington's disease","volume":"38","author":"Myers","year":"1988","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nbd.2008.01.015_bb0215","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.nbd.2008.01.015_bb0220","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","article-title":"Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus","volume":"16","author":"Nibuya","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.01.015_bb0225","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"issue":"3","key":"10.1016\/j.nbd.2008.01.015_bb0230","first-page":"216","article-title":"Obsessive compulsive disorder in Huntington disease: a case of isolated obsessions successfully treated with sertraline","volume":"15","author":"Patzold","year":"2002","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2008.01.015_bb0235","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1471-4159.2005.03047.x","article-title":"Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease","volume":"93","author":"Pineda","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2008.01.015_bb0240","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/01.wnr.0000236855.85962.f6","article-title":"Limbic neurogenesis\/plasticity in the R6\/2 mouse model of Huntington's disease","volume":"17","author":"Phillips","year":"2006","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2008.01.015_bb0245","doi-asserted-by":"crossref","first-page":"11564","DOI":"10.1523\/JNEUROSCI.3796-05.2005","article-title":"Abnormalities of neurogenesis in the R6\/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment","volume":"25","author":"Phillips","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.01.015_bb0250","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1176\/jnp.8.3.338","article-title":"Sertraline in the treatment of severe aggressiveness in Huntington's disease","volume":"8","author":"Ranen","year":"1996","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.nbd.2008.01.015_bb0255","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.01.015_bb0260","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1046\/j.1471-4159.1999.721773.x","article-title":"Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation","volume":"72","author":"Reynolds","year":"1999","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.nbd.2008.01.015_bb0265","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0304-3940(87)90639-2","article-title":"Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain","volume":"78","author":"Reynolds","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2008.01.015_bb0270","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2008.01.015_bb0275","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrm1742","article-title":"Opinion: what is the role of protein aggregation in neurodegeneration?","volume":"6","author":"Ross","year":"2005","journal-title":"Nat. Rev., Mol. Cell Biol."},{"key":"10.1016\/j.nbd.2008.01.015_bb0280","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2165\/00023210-200317120-00001","article-title":"Neural transplantation in patients with Huntington's disease","volume":"17","author":"Rosser","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nbd.2008.01.015_bb0285","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2008.01.015_bb0290","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nature02553","article-title":"Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus","volume":"429","author":"Schmidt-Hieber","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2008.01.015_bb0295","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.STR.31.9.2212","article-title":"Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia","volume":"31","author":"Schabitz","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.nbd.2008.01.015_bb0300","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1017\/S109285290002201X","article-title":"Depression and Huntington's disease: prevelance, clinical manifestations, etiology, and treatment","volume":"6","author":"Slaughter","year":"2001","journal-title":"CNS Spectr."},{"key":"10.1016\/j.nbd.2008.01.015_bb0305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/j.nbd.2008.01.015_bb0310","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0306-4522(00)00151-2","article-title":"X-irradiation causes a prolonged reduction in cell proliferation in the dentate gyrus of adult rats","volume":"99","author":"Tada","year":"2000","journal-title":"Neurosci."},{"key":"10.1016\/j.nbd.2008.01.015_bb0315","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.neuroscience.2004.04.061","article-title":"Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease","volume":"127","author":"Tattersfield","year":"2004","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.nbd.2008.01.015_bb0320","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0169-328X(98)00173-9","article-title":"Changes in proliferating cell nuclear antigen, a protein involved in DNA repair, in vulnerable hippocampal neurons following global cerebral ischemia","volume":"60","author":"Tomasevic","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"6","key":"10.1016\/j.nbd.2008.01.015_bb0325","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2008.01.015_bb0330","unstructured":"Wong, J.W., Armour, E., Kazanzedis, P., Iordachita, I., Tryggestad, E., Deng, H., et al. submitted for publication. A high-resolution small animal radiation research platform (SARRP) with X-ray CT guidance. Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.nbd.2008.01.015_bb0335","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0149-06.2006","article-title":"Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum","volume":"26","author":"Yamashita","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.01.015_bb0340","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1046\/j.1471-4159.2002.01084.x","article-title":"Inhibition of tryptophan hydroxylase activity and decreased 5-HT1A receptor binding in a mouse model of Huntington's disease","volume":"82","author":"Yohrling","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2008.01.015_bb0345","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchromb.2005.01.027","article-title":"Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry","volume":"819","author":"Zhao","year":"2005","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.nbd.2008.01.015_bb0350","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."},{"issue":"5\u20136","key":"10.1016\/j.nbd.2008.01.015_bb0355","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."},{"issue":"5529","key":"10.1016\/j.nbd.2008.01.015_bb0360","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.nbd.2008.01.015_bb0365","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery","volume":"52","author":"Zuccato","year":"2005","journal-title":"Pharmacol. Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:02:41Z","timestamp":1760850161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996108000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0969996108000259"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2008.01.015","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2008.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}